Effect of TAVR Approach and Other Baseline Factors on the Incidence of Acute Kidney Injury: A Systematic Review and Meta-Analysis

Table 1

Table showing a summary of crude RRs of each assessed predictor for AKI among patients undergoing TAVR.

Factor	Number of studies	AKI group-total	AKI group having predictor factor	Non-AKI group-total	Non-AKI group having predictor factor	Odds ratio	Confidence interval	value	Heterogeneity ( value, I^2)
Male gender	8	391	187	1642	776	1.04	0.83–1.31	0.73	0.49, 0%
Smoking	2	64	4	388	34	0.79	0.09–7.23	0.84
Hypertension	8	374	319	1642	508	2.54	0.35–18.5	0.36	< 0.0001, 92%
Diabetes mellitus	8	391	111	1642	435	1.30	0.85–2.00	0.22	0.06, 49%
Atrial fibrillation	3	248	66	1130	317	0.98	0.73–1.38	0.98	0.47, 0%
Coronary artery disease	8	391	170	1642	698	1.06	0.84–1.35	0.62	0.60, 0%
Congestive heart failure	3	246	165	1014	576	1.48	1.10–2.00	0.01	0.86, 0%
Peripheral vascular disease	7	376	138	1605	432	1.72	1.35–2.20	< 0.0001	0.90, 0%
Blood transfusion	7	376	189	1602	509	2.45	1.90–3.15	< 0.001	0.59, 0%